Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors

Ann Oncol. 2016 Apr;27(4):746-7. doi: 10.1093/annonc/mdv626. Epub 2015 Dec 27.

Authors

R C S van Adrichem¹, K Kamp¹, T Vandamme², M Peeters², R A Feelders¹, W W de Herder³

Affiliations

¹ Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands.
² Department of Oncology, University of Antwerp, Antwerp, Belgium.
³ Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands w.w.deherder@erasmusmc.nl.

PMID: 26712902
DOI: 10.1093/annonc/mdv626

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Disease-Free Survival
Female
Humans
Intestinal Neoplasms / blood*
Intestinal Neoplasms / pathology
Male
Middle Aged
Neuroendocrine Tumors / blood*
Neuroendocrine Tumors / pathology
Neurons / enzymology
Neurons / pathology
Pancreatic Neoplasms / blood*
Pancreatic Neoplasms / pathology
Phosphopyruvate Hydratase / blood*
Prognosis*
Stomach Neoplasms / blood*
Stomach Neoplasms / pathology

Substances

Phosphopyruvate Hydratase

Supplementary concepts

Gastro-enteropancreatic neuroendocrine tumor